✦ LIBER ✦

Validation of molecular targets in prostate cancer

✍ Scribed by JACK A. SCHALKEN

Book ID: 109052146
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 227 KB
Volume: 96
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2005.05943.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeted therapy in prostate cancer

✍ Niall M Corcoran; Martin E Gleave 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB

Cyclooxygenase-2 (COX-2): a molecular ta

Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer

✍ G. Aparicio Gallego; S. Díaz Prado; P. Jiménez Fonseca; R. García Campelo; J. Ca 📂 Article 📅 2007 🏛 Springer Milan 🌐 Spanish ⚖ 561 KB

Novel Molecular Targets ofAzadirachta in

Novel Molecular Targets ofAzadirachta indicaAssociated with Inhibition of Tumor Growth in Prostate Cancer

✍ Saswati Mahapatra; R. Jeffrey Karnes; Michael W. Holmes; Charles Y. F. Young; Jo 📂 Article 📅 2011 🏛 American Association of Pharmaceutical Scientists 🌐 English ⚖ 909 KB

Advanced prostate cancer has significant long-term morbidity, and there is a growing interest in alternative and complimentary forms of therapy that will improve the outcomes of patients. __Azadirachta indica__ (common name: neem) contains multiple active compounds that have potent anti-inflammatory

Targeted treatment of prostate cancer

✍ Xinning Wang; Lihong Yin; Pravin Rao; Robert Stein; Kelley M. Harsch; Zhenghong 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

## Abstract Over a half century ago, Charles Huggins demonstrated the response of prostate cancer to androgen deprivation therapy. Subsequently, many discoveries and evolving findings continued to support a research rationale focused on the androgen receptor (AR) as a key target for prostate cancer

Molecular targets of cancer chemotherapy

✍ K. S. Zaenker; G. Mustacchi; E. Mihich 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 171 KB

Molecular imaging in prostate cancer

✍ Jose A. Karam; Ralph P. Mason; Kenneth S. Koeneman; Peter P. Antich; Elie A. Ben 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 354 KB

## Abstract Prostate cancer (PCa) is the most common non‐cutaneous malignancy in men. New ways to diagnose this cancer in its early stages are needed. Unique genetic and biochemical changes in the cell pave the way for tumors to grow and metastasize. Novel imaging approaches attempt to detect patho